Invigorate
发表于 2025-3-25 04:28:37
http://reply.papertrans.cn/3/237/23697/23697-21.png
迅速成长
发表于 2025-3-25 09:24:21
Submitted on: 13 October 2018.
Revised on: 21 October 2018.
Accepted on: 05 November 2018.
Ophthalmology and Therapy---SPRINGER INT PUBL AG
Common-Migraine
发表于 2025-3-25 12:37:53
Submitted on: 18 July 2022.
Revised on: 27 August 2022.
Accepted on: 03 September 2022.
Ophthalmology and Therapy
陈腐思想
发表于 2025-3-25 16:30:32
Submitted on: 03 August 2006.
Revised on: 11 September 2006.
Accepted on: 08 October 2006.
Ophthalmology and Therapy---SPRINGER INT PUBL AG
烧烤
发表于 2025-3-25 22:36:47
Submitted on: 15 February 2009.
Revised on: 25 March 2009.
Accepted on: 20 April 2009.
Ophthalmology and Therapy
forthy
发表于 2025-3-26 00:26:28
Submitted on: 21 November 2006.
Revised on: 05 December 2006.
Accepted on: 29 December 2006.
Ophthalmology and Therapy
吼叫
发表于 2025-3-26 04:45:13
http://reply.papertrans.cn/3/237/23697/23697-27.png
欢呼
发表于 2025-3-26 10:30:42
Submitted on: 01 July 2001.
Revised on: 11 July 2001.
Accepted on: 19 July 2001.
Ophthalmology and Therapy
BUDGE
发表于 2025-3-26 14:18:06
Submitted on: 02 May 2003.
Revised on: 30 May 2003.
Accepted on: 26 June 2003.
Ophthalmology and Therapy---SPRINGER INT PUBL AG
受人支配
发表于 2025-3-26 19:48:28
Submitted on: 01 August 2004.
Revised on: 04 September 2004.
Accepted on: 10 September 2004.
Ophthalmology and Therapy---SPRINGER INT PUBL AG